2020
DOI: 10.1007/s12149-020-01503-5
|View full text |Cite
|
Sign up to set email alerts
|

SPECT-CT visualization and biopsy of sentinel lymph nodes in patients with stage IAB–IIA cervical cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 20 publications
0
1
0
1
Order By: Relevance
“…Hoogendam et al 10 reported that the overall detection rate of SLN by SPECT/CT was 93.1%, whereas the overall detection rate with LSG was 91% in patients with cervical cancer. Previous studies have shown that the overall identification rates of SLNs by SPECT/CT or LSG are 92.2% to 100% 6,8–12 and 70% to 100%, 6,8–10 respectively (Table 4). Many studies have reported that SPECT/CT for preoperative localization can improve the SLN identification rate compared with LSG for various types of cancer 13,14 .…”
Section: Discussionmentioning
confidence: 95%
“…Hoogendam et al 10 reported that the overall detection rate of SLN by SPECT/CT was 93.1%, whereas the overall detection rate with LSG was 91% in patients with cervical cancer. Previous studies have shown that the overall identification rates of SLNs by SPECT/CT or LSG are 92.2% to 100% 6,8–12 and 70% to 100%, 6,8–10 respectively (Table 4). Many studies have reported that SPECT/CT for preoperative localization can improve the SLN identification rate compared with LSG for various types of cancer 13,14 .…”
Section: Discussionmentioning
confidence: 95%
“…В настоящее время имеются сообщения об использовании данных радионуклидной визуализации путей лимфооттока от первичной опухоли при определении топографии радиационных полей у больных раком молочной железы, предстательной железы, раком шейки матки [1,3,13,21]. рядом авторов [8,10,20] было высказано предположение, что указанные подходы могут быть использованы при планировании лучевой терапии у больных злокачественными новообразованиями головы и шеи.…”
unclassified